Table of Contents Table of Contents
Previous Page  1115 / 1983 Next Page
Information
Show Menu
Previous Page 1115 / 1983 Next Page
Page Background

EBRO

2017

Gastric cancer adjuvant chemoradiation

D2 or not D2?

Operative mortality ≥ 10% in D2 patients

No survival benefit for D2 dissection

But modern Japanese trials consistently show ~ 1%

post-operative mortality for ≥ D2 surgery